← back to search

Dongyuan Xing

North Minzu University · US
Area of research
Endocrinology, Diabetes and Metabolism · Genetics
Research interest
Research interests include Diabetes Management and Research, Hyperglycemia and glycemic control in critically ill and hospitalized patients, Diabetes and associated disorders, and Pancreatic function and diabetes.
h-index
30
citations
5,510
works
61
NIH funding
primary concept
Medicine
email

Recent publications

Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma
Journal of Clinical Oncology 2024cited by 20position: middledoi
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
New England Journal of Medicine 2021cited by 1,728position: middledoi
Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study
Clinical Cancer Research 2021cited by 136position: middledoi
Phase 3 trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) or everolimus (EVE) versus sunitinib (SUN) monotherapy as a first-line treatment for patients (pts) with advanced renal cell carcinoma (RCC) (CLEAR study).
Journal of Clinical Oncology 2021cited by 36position: middledoi
Severe Hypoglycemia and Diabetic Ketoacidosis in Adults With Type 1 Diabetes: Results From the T1D Exchange Clinic Registry
The Journal of Clinical Endocrinology & Metabolism 2013cited by 334position: middledoi
Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry
Pediatric Diabetes 2013cited by 244position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Kellee M. Miller · Shawnee Mission Northwest High School2 papers (2013–2013)Stephanie N. DuBose · Emory University2 papers (2013–2013)Roy W. Beck · Diabetes Australia2 papers (2013–2013) · 1 papers (2021–2021) · 1 papers (2024–2024)Masatoshi Eto · Graduate School of Medical Sciences1 papers (2021–2021)Larisa J. Geskin · Columbia University Irving Medical Center1 papers (2024–2024)Nicholas Sauter · Novartis (Switzerland)1 papers (2024–2024)Anne L. Peters · University of Southern California1 papers (2013–2013)Viktor Grünwald · Dana-Farber Cancer Institute1 papers (2021–2021)William V. Tamborlane · Yale University1 papers (2013–2013)Eleni Andreopoulou · Cornell University1 papers (2021–2021)Timothy M. Kuzel · Northwestern University1 papers (2024–2024)Sung‐Hoo Hong · Seoul National University1 papers (2021–2021)Anil Kapoor · McMaster University1 papers (2021–2021)Tatyana Feldman · Hackensack University Medical Center1 papers (2024–2024)Peter A. Kaufman · University of Vermont1 papers (2021–2021) · 1 papers (2024–2024)Pamela B. Allen · Emory University1 papers (2024–2024)Arleta Rewers · I.R.C.C.S. Oasi Maria SS1 papers (2013–2013)